Talks and presentations

• Guest lecture: “Analytics and modeling to support public health decision-making”. Epidemology 800, Boston University School of Public Healthy (Nov 2024)

• Conference talk: “Real-time use of a dynamic model to measure the impact of public health interventions on measles outbreak size and duration – Chicago, Illinois, 2024”. IDM Symposium (Oct 2024)

• Conference talk: “Modeling and forecasting using genomic surveillance: lessons from wastewater and COVID-19 variants”. IDM Symposium (Oct 2024)

• Conference talk: “Prospective demand for nirsevimab to protect U.S. infants and young children against respiratory syncytial virus in the 2024/2025 season”. National Immunization Conference (Sep 2024)

• Guest lecture: “Wastewater-informed forecasts of COVID-19 hospital admissions”. Infectious Disease Dynamics: Theoretical and Computational Approaches, Johns Hopkins University (May 2024)

• Invited talk: “Indoor air quality and infectious disease modeling”. CU Improve Workshop, Columbia University (May 2023)

• Invited talk: “Wastewater-based epidemiology for biosecurity”. Council on Strategic Risks (Sep 2022)

• Invited talk: “Wastewater-based epidemiology: analysis and applications”. Harvard University, Seminar on Technology Assessment in Health Care (Apr 2022)

• Talk: “Interpreting Covid-19 Wastewater Monitoring Data from Buildings to Support Disease Mitigation”. WEF Public Health and Water Conference (Mar 2022)

• Invited talk: “Applications of infectious disease modeling: antibiotic resistance and Covid-19”. Georgetown University, Dept. of Epidemiology ()

• Invited talk: “Career Chat”. Vivify Space Club (Feb 2022)

• Talk: “Interpreting wastewater data from buildings”. Wastewater Surveillance for SARS-CoV-2: Fall RCN Meeting (Nov 2021)

• Invited talk: “Wastewater monitoring of SARS-CoV-2 to inform community- and building-level public health action”. Library of Congress (Jul 2021)

• Invited talk: “Improving safety and scale: the role of stool banks in C. difficile treatment and in research”. Fred Hutch Microbiome Symposium (Apr 2020)

• Invited talk: “Regulating fecal microbiota transplantation”. RAND Boston (Jan 2020)

• Invited talk: “Data-driven approaches to antimicrobial resistance policy”. NIAID, NIH (Dec 2019)

• Invited talk: “Fecal microbiota transplantation: the role of the donor in treating C. difficile and other diseases”. Rochester Institute of Technology, School of Life Sciences (Nov 2019)

• Invited talk: “Bugs and drugs: How (and how much) does changing antibiotic use change antibiotic resistance?”. Kolokotrones Seminar, Harvard Chan School of Public Health (Nov 2019)

• Oral abstract: “Azithromycin susceptibility in Neisseria gonorrhoeae and seasonal macrolide use”. STD Prevention Conference, DC (Sep 2018)

• Invited talk: “What’s causing azithromycin nonsusceptibility in Neisseria gonorrhoeae?”. Massachusetts Department of Public Health (Apr 2018)

• Talk: “Ecological association between unequal antibiotic consumption and antibiotic resistance”. Epidemics (Dec 2017)

• Oral abstract: “Antibiotic consumption and antibiotic resistance across organisms, drugs, and consumer groups.”. ID Week (Oct 2017)

• Invited talk: “Discovering hidden ecological relationships between bacteria using modeling and statistics.”. Williams College, Department of Statistics (Oct 2016)

• Poster: “Dynamics of high-salt-induced gut microbiome alterations in mice”. N Wilck, DN Muller, SW Olesen, MG Matus, S Kearney, EJ Alm. Keystone C1 (Gut Microbiota Modulation of Host Physiology) (Mar 2015)

• Poster: “A high-salt diet in mice increases the prevalence of a commensal gut microbe linked to other unhealthy diets”. SW Olesen, MG Matus, A Perrotta, M Smith, EJ Alm. Keystone D1 (Exploiting and Understanding Chemical Biotransformations in the Human Microbiome) (Apr 2014)